103 related articles for article (PubMed ID: 22365988)
1. Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
Peng B; Yi S; Gu Y; Zheng G; He Z
Protein Expr Purif; 2012 Apr; 82(2):360-7. PubMed ID: 22365988
[TBL] [Abstract][Full Text] [Related]
2. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
[TBL] [Abstract][Full Text] [Related]
3. Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma.
Peng B; Gu Y; Xiong Y; Zheng G; He Z
PLoS One; 2012; 7(12):e51413. PubMed ID: 23251525
[TBL] [Abstract][Full Text] [Related]
4. TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway.
Gu Y; Fan S; Liu B; Zheng G; Yu Y; Ouyang Y; He Z
Mol Cell Biochem; 2011 Nov; 357(1-2):107-13. PubMed ID: 21603883
[TBL] [Abstract][Full Text] [Related]
5. TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells.
Liu X; Wang C; Gu Y; Zhang Z; Zheng G; He Z
Mol Cell Biochem; 2015 Jan; 398(1-2):175-83. PubMed ID: 25260657
[TBL] [Abstract][Full Text] [Related]
6. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells.
Zheng G; Zhou M; Ou X; Peng B; Yu Y; Kong F; Ouyang Y; He Z
FEBS J; 2010 Nov; 277(21):4506-18. PubMed ID: 21040473
[TBL] [Abstract][Full Text] [Related]
7. TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.
Jia X; Zhang Z; Luo K; Zheng G; Lu M; Song Y; Liu H; Qiu H; He Z
Sci Rep; 2017 Jun; 7(1):3744. PubMed ID: 28623290
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
Gu Y; Zhang Z; Yin J; Ye J; Song Y; Liu H; Xiong Y; Lu M; Zheng G; He Z
J Exp Clin Cancer Res; 2017 Aug; 36(1):114. PubMed ID: 28859669
[TBL] [Abstract][Full Text] [Related]
9. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
10. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
11. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line.
Zhang P; Zhang Z; Zhou X; Qiu W; Chen F; Chen W
BMC Cancer; 2006 Sep; 6():224. PubMed ID: 16978399
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
13. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
[TBL] [Abstract][Full Text] [Related]
14. [The effect of ginkgolic acids on multidrug resistance in oral squamous cell carcinoma].
Wang H; Zhou CC; Feng Y; Dai LN; Chen J; Chen SX; Li XY; Liu YR; Zhang P
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Dec; 28(6):668-71. PubMed ID: 21365850
[TBL] [Abstract][Full Text] [Related]
15. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
Zhang B; Liu M; Tang HK; Ma HB; Wang C; Chen X; Huang HZ
J Oral Pathol Med; 2012 Feb; 41(2):141-8. PubMed ID: 21793937
[TBL] [Abstract][Full Text] [Related]
16. TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF‑7 cells.
Zhao S; Li X; Yin L; Hou L; Lan J; Zhu X
Oncol Rep; 2020 Jun; 43(6):2017-2027. PubMed ID: 32323833
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
19. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.
Harada K; Ferdous T; Ueyama Y
Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines.
Choi HS; Kim YK; Yun PY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
